# Mimio Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mimio-health

- Industry: Pharmaceuticals
- Headquarters: San Francisco, US
- Website: mimiohealth.com
- Total disclosed funding: $2.5M
- Latest round: Seed (Mar 15, 2023)
- Investors on record: 6

## About

Based in California, US, and founded in 2022, Mimio Health, Inc. operates as a pharmaceutical company that engages in selling alternative food supplements. In March 2023, Mimio Health, Inc. raised USD 2.5 million in seed funding led by Better Ventures, with participation from Gaingels Syndicate, R42, SOSV, Thia Ventures, and What If Ventures.

Mimio is a biomimetic supplement that activates your biology to support optimized metabolism and energy, reduced appetite and cravings, improved mood and cognition, enhanced performance and recovery, and healthy aging. Mimio was designed from fasting research to help you unlock the benefits of fasting on demand. It uses a unique combination of clinically-validated fasting metabolites to help activate your cells’ natural ability to clean, repair, and protect themselves.

The company plans to use the funding to keep growing its product range, carry out further clinical research, and keep up its hunt for new biomimetic formulations.

## Funding rounds

- Seed, Mar 15, 2023, $2.5M — SOSV, Better Ventures, Gaingels, What If Ventures, R42, Thia Ventures

## Investors

- SOSV (https://capitalatlas.ai/funds/sosv) — Seed
- Better Ventures — Seed
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Seed
- What If Ventures (https://capitalatlas.ai/funds/what-if-ventures) — Seed
- R42 (https://capitalatlas.ai/funds/r42) — Seed
- Thia Ventures (https://capitalatlas.ai/funds/thia-ventures) — Seed